Skip to main content
. 2015 Apr 25;34(1):38. doi: 10.1186/s13046-015-0157-2

Figure 2.

Figure 2

Synergistic drug combinations in JC and JC-pl. A: Comparison of expected and observed relative viability of JC after combination treatment with EPD and paclitaxel. B: Lower doses of EPD and cisplatin were found to be antagonistic for JC-pl, whereas the higher doses showed synergistic effects.